Form 4 for CAC CAMDEN NATIONAL CORP
Accepted 2024-03-21 00:00:00 ET · period of report 2024-03-20 · accession 0000750686-24-000092 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-21 | 2024-03-20 | CAC | Denekas Craig N | Dir | A - Grant | $32.31 | +365 | 11.2K | +3% | +$11.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-20 | A | A | 365 | $32.31 | 11,150 | D | — | — | (F1) Shares acquired under Camden National Corporation's 2022 Equity and Incentive Plan in lieu of director fees. |